To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Speech in Commons Chamber - Mon 16 Mar 2026
Strait of Hormuz

"Surely the problem we have is that the Government, having decided not to be involved in this, and then literally a day later deciding that they would be involved by granting America the use of our bases, have brought us into a war. Like it or not, that is where …..."
Iain Duncan Smith - View Speech

View all Iain Duncan Smith (Con - Chingford and Woodford Green) contributions to the debate on: Strait of Hormuz

Speech in Commons Chamber - Mon 16 Mar 2026
Oral Answers to Questions

"In the last few weeks, the Prime Minister has been very clear about what he considers our role to be, under international law, if we believe that allies are being attacked. Does he see Ukraine as having exactly the same status as an ally? Does he believe that we are, …..."
Iain Duncan Smith - View Speech

View all Iain Duncan Smith (Con - Chingford and Woodford Green) contributions to the debate on: Oral Answers to Questions

Written Question
Cancer: Vaccination
Monday 16th March 2026

Asked by: Iain Duncan Smith (Conservative - Chingford and Woodford Green)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure NHS professionals are aware of personalised cancer vaccines.

Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)

The NHS Cancer Vaccine Launch Pad (CVLP) is a platform set up to accelerate the development of cancer vaccines and speed up access to mRNA personalised cancer vaccine clinical trials for cancer patients. The CVLP has been instrumental in accelerating trial activity in cancer research, with CVLP sites driving faster activation and enrolment timelines.

The CVLP provides an extended network of referral sites to broaden trial access and to identify eligible patients through genetic analysis, working with the Vaccine Innovation Pathway to optimise patient recruitment. This means that patients can be recruited from across parts of the country and means that the United Kingdom was the fastest recruiting country for the first international trial of personalised vaccination after surgery for colorectal cancer.

As the CVLP continues its phased scale-up across the country, professional awareness is being driven by the expansion of participating trial sites and use of the referral network.


Speech in Commons Chamber - Thu 12 Mar 2026
Oral Answers to Questions

"Small-volume business manufacturers in the automotive sector are having a terrible time at the moment. They rely on exports, and exports to the US are critical. Although I welcome the agreement the Government struck, costs are still four times what they were before President Trump introduced his tariffs, and those …..."
Iain Duncan Smith - View Speech

View all Iain Duncan Smith (Con - Chingford and Woodford Green) contributions to the debate on: Oral Answers to Questions

Written Question
Motor Vehicles: USA
Thursday 12th March 2026

Asked by: Iain Duncan Smith (Conservative - Chingford and Woodford Green)

Question to the Department for Business and Trade:

To ask the Secretary of State for Business and Trade, what steps his Department is taking to help small-volume automotive manufacturers access the US market.

Answered by Chris Bryant - Minister of State (Department for Business and Trade)

The Economic Prosperity Deal has reduced tariffs for UK exporters in critical sectors such as the car industry - this includes a preferential rate of 10% on 100,000 UK cars exported to the US each year.

The UK exports around 100,000 cars a year, so this quota will ensure most cars entering the US will do so at a preferential rate.

We are also providing targeted export support through our exports programme and engaging in wider trade policy dialogues with the US.


Division Vote (Commons)
11 Mar 2026 - Finance (No. 2) Bill - View Vote Context
Iain Duncan Smith (Con) voted Aye - in line with the party majority and against the House
One of 94 Conservative Aye votes vs 0 Conservative No votes
Vote Tally: Ayes - 172 Noes - 283
Division Vote (Commons)
11 Mar 2026 - Finance (No. 2) Bill - View Vote Context
Iain Duncan Smith (Con) voted No - in line with the party majority and against the House
One of 92 Conservative No votes vs 0 Conservative Aye votes
Vote Tally: Ayes - 292 Noes - 161
Division Vote (Commons)
11 Mar 2026 - Finance (No. 2) Bill - View Vote Context
Iain Duncan Smith (Con) voted Aye - in line with the party majority and against the House
One of 96 Conservative Aye votes vs 0 Conservative No votes
Vote Tally: Ayes - 174 Noes - 292
Division Vote (Commons)
11 Mar 2026 - Finance (No. 2) Bill - View Vote Context
Iain Duncan Smith (Con) voted Aye - in line with the party majority and against the House
One of 93 Conservative Aye votes vs 0 Conservative No votes
Vote Tally: Ayes - 175 Noes - 292
Written Question
Craig Foreman and Lindsay Foreman
Wednesday 11th March 2026

Asked by: Iain Duncan Smith (Conservative - Chingford and Woodford Green)

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps she is taking to secure the release of Lindsay and Craig Foreman.

Answered by Hamish Falconer - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

I refer the Rt Hon Member to the answer provided on 11 March in response to Question 114825.